Gambogenic acid

Ask supplier a question | View on supplier's website

Gambogenic Acid, identified from Gamboge, is an inhibitor of the FGFR signaling pathway in erlotinib-resistant non-small-cell lung cancer (NSCLC) and exhibits anti-tumor effects. Gambogenic acid acts is also an effective inhibitor of EZH2 that specifically and covalently binds to Cys668 within the EZH2-SET domain, and triggers EZH2 ubiquitination.

Supplier	Selleck Chemicals
Product #	S9031
Sku #	S9031-10mg
Pricing	10mg, $670.00

Feedback